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Abstract
Verotoxin (VT) binding to the trisaccharide portion of globotriaosyl ceramide (Gb3) is believed to be a crucial step in the
development of hemolytic uremic syndrome (HUS) commonly known as ‘Hamburger disease’. This interaction is the initial
step in the binding process and defines the specificity of verotoxin binding to cellular membranes. Although molecular
modeling, co-crystallization and co-NMR studies with VT and the trisaccharide moiety of Gb3 have indicated potential
multiple sites for Gb3 binding, little is known about their direct effects on kinetic and equilibrium binding. Here we describe
how the binding of radiolabeled VT ([125I]VT1) to Gb3 in a microtiter well format, is driven by two different association rate
constants (k1a = 0.0075 and k1b = 0.275 min31 nM31) with the high affinity site representing 15% of the total specific
binding sites. Binding was reversible at room temperature, reached equilibrium after 2^3 h, and non-specific binding was less
than 5%. Equilibrium binding studies defined by [125I]VT1 saturation binding to 15, 30, 60 and 120 ng Gb3/well, showed the
presence of a single site with dissociation constants (Kds) ranging between 0.5 and 3 nM. However, the maximum density of
specific [125I]VT1 binding sites (Bmax) did not directly correlate with the Gb3 concentration per well : the most[125I]VT1
binding was observed for 60 ng Gb3 (Bmax = 1.28 nM; compared to 0.23 nM for 30 ng Gb3 and 0.65 nM for 120 ng Gb3).
Furthermore, while Hill coefficients (nH) for 15, 30 and 120 ng Gb3 were close to unity indicating single interactions, for the
saturation isotherm for 60 ng Gb3/well nH was 1.4. Subsequent Scatchard analysis yielded a concave downward curve for
[125I]VT1 binding to 60 ng Gb3/well, suggesting positive co-operativity. We present, for the first time, conclusive binding data
confirming the presence of at least two discrete Gb3 binding sites: these multivalent interactions between verotoxin VT-1 and
Gb3 were described by association reactions driven by two distinct rate constants, as well as by the positive co-operativity
governing binding at a restricted receptor concentration. These results imply that the concentration of Gb3 on the surface of
target cells can have a complex, non-linear effect on verotoxin binding and thereby, on sensitivity to cytotoxicity. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
Verotoxin produced by Escherichia coli O157:H7
has been identi¢ed as the cause of hemorrhagic col-
itis (HC) within the gastrointestinal (GI) tract and
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hemolytic uremic syndrome (HUS), the leading
causes of acute pediatric renal failure [1,2]. The bind-
ing of verotoxin to its glycolipid receptor globotriao-
syl ceramide (Gb3 : GalK1-4-GalL1-4 Glc ceramide)
contained within the plasma membrane of endothe-
lial cells of the microvasculature of the pediatric re-
nal glomerulus or the GI tract is considered a crucial
component of the events ¢nally leading to HUS or
HC [2^4].
Systemic toxemia resulting from toxin transloca-
tion from the GI tract during infection with verotox-
in-producing E. coli is believed to be a rather short-
lived event due to a receptor-mediated uptake of the
toxin which results in a systemic half-life of a few
minutes in animal models. This short half-life is a
re£ection of the high a⁄nity verotoxin has for its
receptor glycosphingolipid, Gb3. This a⁄nity, when
measured by binding of puri¢ed verotoxin to Gb3 in
a cholesterol/lectin bilayer structure, has been shown
to be in the range of 1038 M [5]. However, the bind-
ing of verotoxin to the plasma membrane of Gb3-
containing cells can be of the order of 10312 to
10317 M [6,7], making verotoxin one of the most
biologically active molecules known. The discrepancy
in binding a⁄nity between model membranes and
the plasma membrane of real cells indicates complex
interactions of the toxin with its receptor, and illus-
trates how much is yet to be learned about the mech-
anism by which this toxin binds its carbohydrate-
containing lipid conjugate receptor.
Some progress is being made however. The impor-
tance of the lipid moiety is becoming apparent [8^
10]. This is illustrated by the fact that in model stud-
ies, binding to the Gb3 oligosaccharide devoid of its
lipid component, is 1035-fold less than to Gb3 [11],
barely above background and indeed, in our less
sensitive assays, not above background [12]. Other
reports of the interaction of the verotoxin-1 B-sub-
unit with its carbohydrate receptor have proposed
that initial protein^carbohydrate interactions deter-
mine speci¢city, whereas subsequent protein^lipid in-
teractions are required for tight binding [11]. How-
ever, this is unlikely since we have recently generated
monovalent, soluble derivatives of Gb3 which retain
high a⁄nity VT1 binding [10].
1.1. Multi-site binding of verotoxin to
glycosphingolipids
The family of verotoxins (VT1, VT2, VT2c and
VT2e) comprise an enzymatic A chain (32 kDa)
and ¢ve receptor-binding B-subunits (8 kDa each;
[13]). Molecular modeling studies and binding to
Gb3 and Gb4 derivatives have provided evidence
for two Gb3 binding sites per B-subunit monomer
[14,15]. One site (site I) is contained within the cleft
between adjacent B-subunit monomers and the sec-
ond (site II) in a depression in the B-subunit surface
which would lie adjacent to the target cell plasma
membrane and which corresponds to the binding
site predicted from the OB-fold oligomeric binding
motif [16] identi¢ed in the B-subunit crystal struc-
ture. The presence of multiple binding sites on the
B-subunit monomer, together within the pentameric
B-subunit array, suggests that binding to Gb3 might
be a very complex process. Possible positive cooper-
ative interactions between the individual sites could
explain the very high a⁄nity binding of VT to the
plasma membrane Gb3. We also have predicted that
these two binding sites, though available for all mem-
bers of the verotoxin family, are di¡erentially utilized
in di¡erent verotoxins [15]. The cocrystal structure of
the VT1 B-subunit and the lipid-free sugar moiety of
Gb3 have been solved [17], identifying three potential
binding sites. Sites I and II are approximately equiv-
alent to those we predicted [15] and the third site is
essentially binding to Trp-34. The NMR structure of
a similar complex [18] veri¢ed the primary use of site
II as in the cocrystal, but no evidence for site III was
seen. The orientation of the sugar in site II in both
studies, is essentially opposite to that we predicted;
however, the binding to the lipid-free globotriaose is
so weak [11] that the physiological relevance of these
complexes remains questionable. Our £uorescence
energy transfer measurements from a bound coumar-
in derivative of Gb3 to Trp-34 are consistent only
with site II binding [19] as we had modeled [15].
In the current study, we have performed kinetic
binding studies which support the existence of two
sites by demonstrating that the association of vero-
toxin to its glycosphingolipid receptor, Gb3 is driven
by two di¡erent rate constants. In addition, equilib-
rium binding data indicate apparent, positive coop-
erativity for verotoxin binding to speci¢c densities of
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immobilized Gb3, indicating multiple interactions be-
tween the protein VT1 and its glycosphingolipid re-
ceptor.
2. Materials and methods
Evergreen scienti¢c 96-well microplates assay
plates were purchased from Diamed (Mississauga,
Ont.), solvents such as methanol and chloroform
were of reagent grade and purchased from Caledon
(Georgetown, Ont.). The monoclonal antibody PH1
was raised against the B-subunit of verotoxin
[20]. Goat anti-mouse IgG-horseradish peroxidase
(GAM-HRP) was purchased from Bio-Rad (Missis-
sauga, Ont.) and nanoSILG TLC plates from Cale-
don (Mississauga, Ont.). All other reagents were pur-
chased from Sigma-Aldrich (Oakville, Ont.).
VT-1 was isolated and puri¢ed from the high
expression recombinant E. coli pJB28 strain [21]
as described previously [22]. Puri¢ed VT1 was iodi-
nated using iodogen as described [8] to a speci¢c
activity 2^4U105 dpm/Wg. The glycosphingolipid
Gb3 was isolated from the neutral glycolipid frac-
tion from human renal tissue as described previously
[23].
2.1. Analysis of glycosphingolipids
Puri¢ed and modi¢ed glycosphingolipids were an-
alyzed by running 1^5 Wg on silica gel TLC plates in
chloroform:methanol:water (60:35:8) and detected
with orcinol spray (0.5% in 3 M H2SO4 ; 130‡C for
4 min) or iodine vapor.
2.2. Immobilization of glycosphingolipids for
microtiter binding assay
A stock solution of 0.8 Wg glycosphingolipid/ml in
ethanol was prepared and 50 Wl/well was aliquoted
into 96-well assay plates to coat each individual well
with exact amounts of glycosphingolipid (30 ng Gb3
for the kinetic and 15, 30, 60 and 120 ng Gb3 for the
saturation experiments). The plates were then left at
room temperature all day or overnight to allow the
MeOH to evaporate. Once dry, plates were stored
desiccated for up to a week. Prior to use the wells
were blocked with 150 Wl/well 0.2% BSA in PBS for
1 h at room temperature. The well were washed twice
with BSA^PBS prior to assay
2.3. Binding studies using iodinated VT1
2.3.1. Kinetic studies (association and dissociation)
Association experiments (n = 5) were carried out
with individual wells incubated for increasing time
periods (0^180 min) with [125I]VT1 at a ¢xed concen-
tration (1.5 nM in BSA^PBS). For dissociation ex-
periments (n = 5), wells were incubated with [125I]VT1
for 2 h at 23‡C before incubating wells with an excess
of BSA^PBS bu¡er for increasing time periods (0^
240 min and 24 h). Wells were then rinsed three times
in Tris bu¡er (50 mM Tris-HCl, pH 7.4, 4‡C), and
bound [125I]VT1 eluted with 10% SDS, transferred
into tubes and counted using a Wallac gamma-coun-
ter.
2.3.2. Saturation binding
Wells containing increasing concentrations of Gb3
were incubated with 1.5 nM [125I]VT1 for 2 h at
23‡C. Wells were then rinsed three times in Tris bu¡-
er and bound VT1 counted as above.
2.3.3. Calculation of binding parameters
Kinetic rate constants were calculated from the
binding data derived from association and dissocia-
tion experiments using the KINETIC program (KI-
NETIC, EBDA, LIGAND and LOWRY [KELL];
RADLIG Version 4; BioSoft, Cambridge, UK).
The presence of one, two, or three sites was tested
using the F-ratio test in RADLIG Version 4. The
model adopted was that which provided the signi¢-
cantly best ¢t (P6 0.05). In addition, for graphical
estimates of the association rate constant k1, the
pseudo-¢rst order method was used [24]: data were
plotted on a pseudo-¢rst order association plot to
give kobs as its slope. Similarly, in dissociation stud-
ies, results were analyzed by a semilogarithmic plot
of the dissociation data: the natural logarithm (ln) of
B/Bo is plotted as a function of time with the slope of
this line being k31.
Saturation binding data derived from using
[125I]VT1 were analyzed using EBDA and LIGAND
(RADLIG Version 4); [25,26] to estimate binding
parameters (dissociation constants, Kd). Data ¢les
of several saturation curves were run simultaneously
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with LIGAND to obtain ¢nal parameter estimates.
The presence of one, two, or three sites was tested
using the F-ratio test in LIGAND. The model
adopted was that which provided the signi¢cantly
best ¢t (P6 0.05).
3. Results
3.1. Non-speci¢c binding
Binding of [125I]VT1 to uncoated (i.e. without
Gb3) plates was less than 1% of total binding and
therefore negligible. Non-speci¢c binding of
[125I]VT1 to Gb3-coated plates determined by ‘block-
ing’ [125I]VT1 with an anti-VTB antibody for kinetic
studies, or 100 fold excess of unlabeled VT1, for
saturation/equilibrium studies was between 4 and
15% depending on the conditions used. For all sub-
sequent calculations and analysis, only the amount
of speci¢c bound radioligand was used (i.e. total mi-
nus non-speci¢c binding).
3.2. Initial kinetic binding (association/dissociation)
experiments of [125I]VT1 binding to Gb3
These initial association and dissociation experi-
ments indicated that binding of 1.5 nM [125I]VT1
to immobilized 60 ng Gb3 was saturable after 2 h
and also partially reversible under the experimental
conditions applied (Fig. 1). Computer analysis of the
binding data using the non-linear iterative curve-¢t-
ting program KINETIC indicated that a two-site
model gave a signi¢cantly better ¢t (P6 0.005)
than a one- or three-site model (observed association
rate constants kobs = 0.416 þ 0.010 and 0.0141 þ
0.0011 min31) for the association experiment. After
an incubation period of 2 h, the bound [125I]VT1
dissociated from the binding sites with a t66 value
of approximately 4 h and a dissociation rate constant
Fig. 1. Initial kinetic experiments: The top panel shows the binding of [125I]VT1 (1.5 nM) to a Gb3-coated 96-well plate for up to 3 h
followed by incubation with an in¢nite volume of bu¡er to monitor the dissociation of the glycolipid^toxin complex. (a) Association;
(b) dissociation. The lower panel shows the logarithmic transformation of the data: slopes derived from linear regression analysis rep-
resent the observed association rate constant (kobs = 0.032 min31 ; k1 = 1.93U107 min31 M31) and the dissociation rate constant
(k31 = 0.003 min31). However, computer analysis of the binding data using the non-linear iterative curve-¢tting program KINETIC in-
dicated that a two-site model gave a signi¢cantly better ¢t than a one- or three-site model (k1a = 0.745U107 min31 M31 and
k1b = 27.6U107 min31 M31) for the association experiment. Data shown are mean þ S.E.M. (n = 5).
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(k31) of 0.00280 þ 0.00025 min31.(Bmax : 443 þ 9 pM;
after incubating with 1.5 nM [125I]VT1 for 2 h) Con-
sequently, the two association rate constants
(k1 = [kobs3k31]/F ; F = concentration of ‘free li-
gand’) were estimated to be k1a = 0.275 min31
nM31 and k1b = 0.00753 min31 nM31. The propor-
tion of the high to the low a⁄nity sites was approx-
imately 15:85. Using both association and dissocia-
Fig. 2. Saturation isotherms (a,c,e,g) and Scatchard plots (b,d,f,h) of [125I]VT1 binding to immobilized Gb3. (a,b) 15 ng; (c,d) 30 ng;
(e,f) 60 ng; (g,h) 120 ng Gb3 per well). Data shown are mean þ S.E.M. (n = 5).
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tion rate constants, the dissociation constants (Kd)
for [125I]VT1/Gb3 binding were determined to be
Kd(1) = 0.372 nM and Kd(2) = 0.010 nM, with the
high a⁄nity binding site representing 15% of the to-
tal speci¢c binding sites.
3.3. Equilibrium binding: e¡ects of Gb3 density on the
saturation binding of [125I]VT1
Saturation binding experiments with [125I]VT1
binding to 15, 30, 60 and 120 ng/well Gb3 showed
that binding was saturable and the preferred ¢t was a
one-site model (Fig. 2). These saturation experiments
were used to estimate the binding a⁄nity of [125I]VT1
for Gb3 immobilized to 96-well plates, as well as to
further investigate the potential e¡ects of the multi-
valency of the ligand verotoxin binding upon di¡er-
ent Gb3 (‘acceptor’) concentrations/densities. In each
case, a single class of high-a⁄nity binding sites was
identi¢ed with dissociation constants in the nM
range. Whereas Hill-coe⁄cients (nH) for 15, 30 and
120 ng/well Gb3 were close to unity (i.e. nHV1; Ta-
ble 1) indicating a single class of ligands interacting
with a single class of binding sites, for 60 ng Gb3 the
Hill coe⁄cient was signi¢cantly greater than one,
indicating that under these conditions verotoxin dis-
plays multivalent binding with the equivalent of 1.4
distinct binding sites. In addition, the concave down-
ward curve in the Scatchard plot for [125I]VT1 bind-
ing to 60 ng/well Gb3 reinforces positive cooperativ-
ity (Fig. 2f). No consistent change in variation about
the mean as a function of time or VT concentration
was seen.
The estimated 125I-VT1 binding sites (s 1000 pM)
for 60 ng/well Gb3 also suggests cooperative binding
as this is signi¢cantly higher than for 120 ng Gb3/
well (-650 pM-Table 1). This was reproducible with
di¡erent Gb3 and VT1 batches. Association rate
studies with VT1 and Gb3 as variables (Table 2)
resulted in greater Bmax at 60 as compared to 120
ng Gb3/well. Furthermore, a two-site model was pre-
ferred when 0.064 or 0.309 nM VT1 bound 120
ngGb3/well (Table 2), similar to the initial kinetic
results (Fig. 1). This demonstrates the consistency
of results from association and saturation binding.
4. Discussion
The aim of our study was to investigate the com-
plex interactions between verotoxin and its receptor,
globotriaosyl ceramide (Gb3) in relation to the two-
binding site model we have described based on mo-
lecular modeling studies [15]. We have proposed that
the microtiter plate bilayer ¢lm provides a reasonable
approximation to VT binding to plasma membrane
Gb3 [9,27]. In contrast to our previous studies, how-
ever, the present studies have been performed in the
absence of cholesterol and lecithin, due to the poten-
tial modulatory e¡ect of these substituents [27].
While this mode of receptor presentation cannot be
proposed to fully mimic the cell membrane, our con-
clusions are as valid as others [15,17,18] in a thermo-
dynamic context, if not more so, since we analyze
binding to a bilayer structure. As such, the data pro-
vide a baseline for an eventual understanding of the
binding of the toxin to susceptible cells.
Kinetic studies were initially performed to charac-
terize VT binding which demonstrated highly speci¢c
binding of [125I]VT1 and unlabeled VT1 to immobi-
Table 1
Equilibrium binding constants for [125I]VT1 saturation binding to immobilized Gb3
Gb3 (ng/well) [125I]VT1 (nM) Kd (nM) Bmax (pM) nH 2-Site model
15 0.02^9 0.552 þ 0.078 67.3 þ 5.8 0.908 þ 0.079 Ps 0.05
30 0.02^9 0.923 þ 0.194 227 þ 30 0.902 þ 0.125 Ps 0.05
60 0.02^9 3.30 þ 0.36 1280 þ 100 1.363 þ 0.062 Ps 0.05
120 0.02^9 2.60 þ 0.24 648 þ 48 1.018 þ 0.028 Ps 0.05
Dissociation constants (Kd) and maximum density of binding sites (Bmax) were calculated by LIGAND from multiple measurements
(n = 5). In all cases, one-site ¢ts were preferred over two- or three-site models. Hill coe⁄cients are closed to unity (nHV1) for 15, 30,
and 120 ng Gb3 per well-indicating simple interactions between a single receptor type and a single ligand. However, for 60 ng Gb3
per well the Hill coe⁄cient is greater than one, suggesting a more complex binding mechanism, such as positive cooperativity. There-
fore, only apparent values for Kd and Bmax were calculated based on the linear part of the Scatchard plot (shown in italics).
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lized Gb3 with less than 5% non-speci¢c interactions.
Furthermore, equilibrium was reached after 2 h and
binding was reversible in part, under non-cooperative
conditions.
Analysis of the kinetic binding data is based on the
concept that the interaction between the ‘ligand’
(VT1) and immobilized ‘binding sites’ (Gb3) may




VT13Gb3 Kd  k31k1
where k1 and k31 are the respective association
(k1) and dissociation rate (k31) constants with the
dissociation constant Kd de¢ned as the quotient k31/
k1.
Analysis of the kinetic binding data using the non-
linear iterative curve ¢tting program LIGAND
showed that a two-site model was preferred signi¢-
cantly over a one-site ¢t for the association experi-
ment, indicating heterogenous binding. The site to
which [125I]VT1 bound with higher a⁄nity (0.01
nM) consisted of approximately 15% of the total
speci¢c binding sites, whereas the remaining sites
had a lower a⁄nity (0.4 nM) for labeled verotoxin.
However, it remains unproven whether the two-site
model is in fact due to the presence of two receptor
binding sites, I and II, on the holotoxin as described
by Nyholm et al. [15]. Calculations reported in this
study indicated that the interaction energy of the site
II VT1^Gb3 complex is only 50% of that calculated
for site I, which provides a possible explanation for
the presence of a proportion of a second site of lower
a⁄nity found in this association binding experiment.
In contrast, for the dissociation binding experi-
ments a one-site model was preferred over a two-
site ¢t, with 50% of the speci¢c bound [125I]VT1 dis-
sociated from the [125I]VT1^Gb3 complex after
around 4 h, indicating that, under these conditions,
binding is, at least, partially reversible.
4.1. Saturation binding using [125I]VT1
Saturation binding experiments with [125I]VT1
binding to 15, 30, 60 and 120 ng/well Gb3 showed
that binding was saturable and the preferred ¢t was a
one-site model. These saturation experiments were
used to estimate the binding a⁄nity of [125I]VT1
for Gb3 immobilized in microtiter plate wells, as
well as to further investigate the potential e¡ects of
the multivalency of the ligand/verotoxin binding with
di¡erent Gb3 (‘acceptor’) concentrations/densities. In
each case, a single class of high-a⁄nity binding sites
was identi¢ed with dissociation constants in the
nanomolar-range. Whereas Hill-coe⁄cients for 15,
30 and 120 ng/well Gb3 were close to unity (Table
1) indicating a single class of ligands interacting with
a single class of binding sites, for 60 ng Gb3, the Hill
coe⁄cient was signi¢cantly greater than one, indicat-
ing that, under those conditions, verotoxin possesses
1.4 binding sites. In addition, the concave downward
curve in the Scatchard plot for [125I]VT1 binding to
60 ng/well Gb3 also denotes positive cooperativity.
Possible explanations of the positive cooperativity
e¡ect could be that the binding of the ligand (vero-
toxin) to its acceptor site (Gb3) includes feedback-
modulation of ligand conformation consequent to
the binding process (‘a⁄nity conversion’), and/or
steric e¡ects of the multivalent toxin inducing con-
formational changes in adjacent B-subunits, altering
their intrinsic a⁄nities for Gb3. This model of equiv-
alent, but dependent, sites was introduced by Kosh-
land [28], where receptor-induced conformational
changes in the ligand increases the magnitude of
the intrinsic binding constant for successive interac-
tions of ligand. It should be pointed out that no
evidence of cooperativity was observed for the
weak binding of the Gb3 sugar to VT1 [17]. The de-
pendence for cooperative binding on Gb3 concentra-
tion (receptor density), however, might explain in
part, the infrequent observation of cooperative VT
binding to cultured cells [29]. In living cells, the sit-
uation is likely to be more complex due to further
modulation of binding by the membrane phospholip-
id content [27].
The curvature of the Scatchard plot could also be
caused simply by verotoxin binding multivalency.
The dissociation rates were found to be independent
of whether measured in an in¢nite volume or in the
presence of an 100-fold excess of unlabeled VT1 (not
shown). If there was ‘true’ positive cooperativity, the
dissociation rate for the [125I]VT1^Gb3 complex
would decelerate in the presence of an excess of
VT1, indicating an allosteric mechanism [30]. This
suggests that the [125I]VT1^Gb3 complex formation
is supported by an ‘apparent’ positive cooperativity
interaction due to the multivalent nature of the hol-
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otoxin: the initial binding step between Gb3 and a
single site on the holotoxin does not a¡ect the bind-
ing a⁄nity with a neighboring site. These results con-
¢rm previous studies which showed that the weak
binding constant (V1 mM) for soluble trisaccharides
representing the carbohydrate recognition domain of
the B-subunit indicated ¢ve identical non-interacting
carbohydrate binding sites per B-subunit pentamer
and no cooperativity in binding [11]. However, syn-
ergistic binding between individual carbohydrate
binding sites and Gb3s can result in multivalent bind-
ing leading to an increase in a⁄nity: on a cell sur-
face, factors such as membrane £uidity allowing re-
ceptor (Gb3) movement, can play a signi¢cant role
for facilitating cooperative binding of verotoxin,
which could explain the binding of verotoxin to the
plasma membrane of Gb3 containing cells in the or-
der of 10312 to 10317 M [6,7]. The multivalent inter-
action could lead to verotoxin-mediated glycosphin-
golipid clustering, similar to the system of
ganglioside GM1 and cholera toxin B-subunit [31].
However, multivalency does not provide the com-
plete answer for the distinction between verotoxin
binding to Gb3 and its lipid free oligosaccharide.
We have recently synthesized a monomeric, soluble
analog of Gb3 able to inhibit VT/Gb3 binding [10].
Components within the lipid moiety serve to e¡ect an
optimal presentation of the Gb3 sugar for binding,
and this can be mimicked in appropriate chemical
derivatives. We have developed a new glycolipid ox-
idation procedure [32,33] for the generation of such
species which retain, or have higher binding a⁄nity
[32] than natural Gb3.
The kinetic and equilibrium binding studies pre-
sented demonstrate the ¢rst conclusive evidence
that the VT1^Gb3 complex formation, which is
thought to play a crucial role in the process leading
to the development of HUS and subsequent kidney
failure, is in fact highly complex as suggested by
previous studies using computer modeling and co-
crystallization. Under the appropriate conditions,
the B-subunit pentamer can have multi receptor va-
lency resulting in apparent cooperativity and high
a⁄nity binding to Gb3. Receptor binding in a second
site (presumably site II) was con¢rmed by the pres-
ence of a small portion of low-a⁄nity binding sites
as demonstrated by association binding experiments.
The consequences for the development of Gb3-de-
coys to inhibit the binding process of VT1 binding to
Gb3 might be that the most e¡ective design would be
two separate species: one with a high a⁄nity for the
receptor binding site I and the other with a high
a⁄nity for site II, as both sites are involved in
Gb3-binding.
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Table 2
Kinetic experiments to determine the association rate constants (k1) for [125I]VT1 binding to immobilized Gb3 over 3 h
Gb3 (ng/well) [125I]VT1 (nM) kobs (min31) k1 (min31 nM31) Bmax (pM)
30 0.065 0.0191 þ 0.0019 0.288 20.7 þ 1.5
0.318 0.0167 þ 0.0015 0.0516 94.0 þ 5.8
1.520 0.0418 þ 0.0045 0.0274 243 þ 15
60 0.068 0.0212 þ 0.0020 0.312 21.8 þ 1.4
0.352 0.0165 þ 0.0008 0.0466 140 þ 5
1.570 0.0194 þ 0.0012 0.0121 417 þ 18
120 0.064 0.0300 þ 0.0027 0.468 16.9 þ 0.9
0.309 0.0360 þ 0.0044 0.115 88.2 þ 5
1.410 0.0279 þ 0.0015 0.0195 424 þ 14
Values for the observed association rate constant (kobs) and maximum density of [125I]VT1 binding sites (Bmax) were calculated by KI-
NETIC from multiple measurements (n = 6). k1 depends on kobs as well as the concentration of ‘free ligand’ [125I]VT1 (F) :
k1 = [kobs3k31]/F. In general, a one-site ¢t was preferred over a two- or three-site model with the exception when 120 ng Gb3 was in-
cubated with 0.064 or 0.309 nM [125I]VT1: in these cases, a 2-site model was preferred over a one-site ¢t (P6 0.05). For 0.064 nM
[125I]VT1, 16% of the speci¢c binding was driven by a faster rate (k1a = 0.120 min31, k1b = 0.016 min31) and for 0.309 nM
[125I]VT1, 19% of the speci¢c binding was driven by a faster rate (k1a = 0.154 min31, k1b = 0.014 min31)
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